Spira, A. I., Frankel, S. R., Fu, S., Kazmi, S. M. A., Naqash, A. R., Zhu, X., Tripathi, A., Hsu, A., Ahn, J., Orr, D. W., Mumm, J. B. (2025). Phase 1 study of DK2
            <sup>10</sup>
            (EGFR), a tumor-targeted IL2 x IL10 dual immunocytokine, in advanced cancer patients: Dose escalation, immune activation, and safety results.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.2589